29.04.2008 Genentech and Biogen Idec Announce Top-Line Results From Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus

24.04.2008 Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent to $1.12

23.04.2008 Bard Announces First Quarter Results

20.04.2008 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer

16.04.2008 Bard Declares Quarterly Dividend

16.04.2008 Amgen Announces Webcast of 2008 First Quarter Financial Results

14.04.2008 Early Data on Amgen's Anti-Angiogenesis Pipeline Molecules Suggest Biologic Activity Across Tumor Types

10.04.2008 Genentech Announces First Quarter 2008 Results

08.04.2008 Amgen Statement on Romiplostim PDUFA Date

  03.04.2008 Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting

  03.04.2008 National Kidney Foundation Introduces Plan to Track Patients in National Screening Program

02.04.2008 Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women